Laurent Lagrost

Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.

P. Giral, L. Lagrost, I. Beucler, 1998, Metabolism: clinical and experimental.

Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma.

P. Gambert, L. Lagrost, C. Lallemant, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.

J. Dallongeville, P. Giral, L. Lagrost, 1998, Atherosclerosis.

Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.

P. Gambert, L. Lagrost, C. Lallemant, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL.

P. Gambert, L. Lagrost, C. Lallemant, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Induction of apoptosis in endothelial cells treated with cholesterol oxides.

P. Gambert, G. Lizard, L. Lagrost, 1996, The American journal of pathology.

Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall.

S. Monier, P. Gambert, G. Lizard, 1999, Arteriosclerosis, thrombosis, and vascular biology.